Pharmacy- Page 8

Roche ranked the most sustainable healthcare company in the DJSI

November 16, 2020

Pharmacy

The FINANCIAL — For the eleventh time, Roche has been recognised as the most sustainable company in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). This is based on an in-depth analysis of economic, social and environmental performance. The DJSI family of indices serves as a benchmark for investors who integrate sustainability considerations into their portfolios. Roche has

Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH

The FINANCIAL — Gilead Sciences, Inc. and Novo Nordisk A/S announced results

by The FINANCIAL

November 16, 2020

2 mins read

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

The FINANCIAL — Metagenomi, a next generation gene editing company launched by

by The FINANCIAL

November 12, 2020

1 min read

Pharmaceutical industries join to promise fair access to COVID-19 medicines and vaccines

The FINANCIAL — On the occasion of the World Health Assembly, the world’s

by The FINANCIAL

November 12, 2020

1 min read

Pharmacy

Bayer eyes further divestments as profit falls

The FINANCIAL -- In 2017, Bayer’s operational business was at the prior-year level. The company made good progress strategically.

by The FINANCIAL

February 28, 2018

8 mins read

Pharmacy

Merck and Viralytics Announce Acquisition Agreement

The FINANCIAL -- Merck on February 21 announced that the companies have signed a definitive agreement under which it is proposed that Merck, through a subsidiary, will acquire Viralytics, an Australian publicly traded company focused on oncolytic immunotherapy treatments for a range

by The FINANCIAL

February 21, 2018

3 mins read

Pharmacy

US FDA approves Imfinzi for unresectable Stage III non-small cell lung cancer

The FINANCIAL -- AstraZeneca and MedImmune, its global biologics research and development arm, on February 19 announced that the US Food and Drug Administration (FDA) has approved Imfinzi for the treatment of patients with unresectable Stage III non-small cell lung cancer (NSCLC)

by The FINANCIAL

February 19, 2018

1 min read

Pharmacy

Roche to acquire Flatiron Health

The FINANCIAL -- Roche and Flatiron Health, Inc. announced on February 15 that the two partners have signed a definitive agreement under which Roche will acquire all shares of Flatiron Health, following on from an existing equity stake of 12.6%.

by The FINANCIAL

February 16, 2018

1 min read

Pharmacy

Roche purchases shares in tender offer for Ignyta, Inc.

The FINANCIAL -- Roche and Ignyta, Inc. on February 8 announced that Roche’s wholly owned subsidiary Abingdon Acquisition Corp., has accepted for payment all shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common

by The FINANCIAL

February 8, 2018

1 min read

Pharmacy

U.S. Food and Drug Administration Approves Gilead’s Biktarvy

The FINANCIAL -- Gilead Sciences, Inc. on February 7 announced that the U.S. Food and Drug Administration (FDA) has approved Biktarvy (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg, BIC/FTC/TAF), a once-daily single tablet regimen (STR) for the treatment of HIV-1 infection.

by The FINANCIAL

February 8, 2018

3 mins read

Pharmacy

Gilead Reports 4Q Loss

The FINANCIAL -- Gilead Sciences, Inc. announced on February 6 its results of operations for the fourth quarter and full year 2017.

by The FINANCIAL

February 7, 2018

6 mins read

Pharmacy

Bristol-Myers Squibb Co. Reveals Increase In Q4 Earnings

The FINANCIAL -- Bristol-Myers Squibb Company on February 5 reported results for the fourth quarter and full year of 2017, which were highlighted by strong sales for Opdivo and Eliquis along with regulatory and clinical progress in Oncology for Opdivo and the

by The FINANCIAL

February 5, 2018

5 mins read

Pharmacy

Amgen Q4 earnings fall short of expectations

The FINANCIAL -- Amgen on February 1 announced financial results for the fourth quarter and full year 2017. Key results include:

by The FINANCIAL

February 2, 2018

8 mins read

Pharmacy

Merck posts mixed fourth-quarter results

The FINANCIAL -- Merck known as MSD outside the United States and Canada, on February 2 announced financial results for the fourth quarter and full year of 2017.

by The FINANCIAL

February 2, 2018

11 mins read